MAFEPAIN

SPIMACO ADDWAEIH
Identification
- Active ingredient (INN)
- ACIDE MEFENAMIQUE
- Internal code
- 04 B 070
- Country of Origin
- Saudi Arabia
- Pharmaceutical form
- Scored Coated Tablet
- Prescription List
- Regulated (List II)
- Packaging
- b/20

DAWA Clinical Workbench v2.0
Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.
Description
A non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties.
It is an inhibitor of cyclooxygenase.
Indications
For the treatment of rheumatoid arthritis, osteoarthritis, dysmenorrhea, and mild to moderate pain, inflammation, and fever.
Pharmacodynamics
Mefenamic acid, an anthranilic acid derivative, is a member of the fenamate group of nonsteroidal anti-inflammatory drugs (NSAIDs).
It exhibits anti-inflammatory, analgesic, and antipyretic activities.
Similar to other
NSAIDs, mefenamic acid inhibits prostaglandin synthetase.
Absorption
Mefenamic acid is rapidly absorbed after oral administration.
Metabolism
Mefenamic acid undergoes metabolism by
CYP2C9 to 3-hydroxymethyl mefenamic acid, and further oxidation to a 3-carboxymefenamic acid may occur.
The activity of these metabolites has not been studied.
Mefenamic acid is also glucuronidated directly.
Hover over products below to view reaction partners Mefenamic acid 3-hydroxymethyl mefenamic aci.
Route of Elimination
The fecal route of elimination accounts for up to 20% of the dose, mainly in the form of unconjugated 3-carboxymefenamic acid.3 The elimination half-life of mefenamic acid is approximately two hours.
Mefenamic acid, its metabolites and conjugates are primarily excreted by the kidneys.
Both renal and hepatic excretion are significant pathways of elimination.
Adverse Effects
Improve decision support & research outcomes With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
View sample adverse effects data in our new Data Library! See the data Improve decision support & research outcomes with our structured adverse effects data.
Toxicity
Oral, rat LD 50: 740 mg/kg. Symptoms of overdose may include severe stomach pain, coffee ground-like vomit, dark stool, ringing in the ears, change in amount of urine, unusually fast or slow heartbeat, muscle weakness, slow or shallow breathing, confusion, severe headache or loss of consciousness.
Warnings
For external use only.
Do not use more than one acne product at a time.
Dosage & Administration
After area is wet with
Blemfree™ Cleansing Wash Concentrate has foamed, tap Blemfree™ Cleansing Spheres with fingertips and massage in small circles for 60 seconds.
Proceed to rinse step.